These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33499813)
41. Identification of biomarkers associated with the recurrence of osteosarcoma using ceRNA regulatory network analysis. Zhang S; Ding L; Li X; Fan H Int J Mol Med; 2019 Apr; 43(4):1723-1733. PubMed ID: 30816442 [TBL] [Abstract][Full Text] [Related]
42. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma. Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G Front Immunol; 2021; 12():706936. PubMed ID: 34899682 [TBL] [Abstract][Full Text] [Related]
43. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Xu Y; Chen J; Yang Z; Xu L Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559 [TBL] [Abstract][Full Text] [Related]
44. Genome-wide identification and functional analysis of lincRNAs acting as miRNA targets or decoys in maize. Fan C; Hao Z; Yan J; Li G BMC Genomics; 2015 Oct; 16():793. PubMed ID: 26470872 [TBL] [Abstract][Full Text] [Related]
45. Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis. Liu J; Li H; Zheng B; Sun L; Yuan Y; Xing C Dig Dis Sci; 2019 Jul; 64(7):1868-1877. PubMed ID: 30734239 [TBL] [Abstract][Full Text] [Related]
46. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis. Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209 [TBL] [Abstract][Full Text] [Related]
47. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD. Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691 [TBL] [Abstract][Full Text] [Related]
48. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis. Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120 [TBL] [Abstract][Full Text] [Related]
49. Integrated analysis of competitive endogenous RNA networks in elder patients with non-small cell lung cancer. Chen Z; Yu F; Zhu B; Li Q; Yu Y; Zong F; Liu W; Zhang M; Wu S Medicine (Baltimore); 2023 Mar; 102(10):e33192. PubMed ID: 36897674 [TBL] [Abstract][Full Text] [Related]
50. Construction and Analysis of lncRNA-Mediated ceRNA Network in Nasopharyngeal Carcinoma Based on Weighted Correlation Network Analysis. Zou Z; Liu S; Ha Y; Huang B Biomed Res Int; 2020; 2020():1468980. PubMed ID: 33102573 [TBL] [Abstract][Full Text] [Related]
51. Identification of a novel lncRNA-miRNA-mRNA competing endogenous RNA network associated with prognosis of breast cancer. Wan X; Hao S; Hu C; Qu R J Biochem Mol Toxicol; 2022 Aug; 36(8):e23089. PubMed ID: 35532246 [TBL] [Abstract][Full Text] [Related]
52. Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme. Zhu X; Jiang L; Yang H; Chen T; Wu X; Lv K Cancer Cell Int; 2020; 20():393. PubMed ID: 32821246 [TBL] [Abstract][Full Text] [Related]
53. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer. Qi M; Yu B; Yu H; Li F Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354 [TBL] [Abstract][Full Text] [Related]
54. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma. Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342 [TBL] [Abstract][Full Text] [Related]
55. Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma. Xi J; Zhang H; Li Y; Su H; Chen X; Liang X Medicine (Baltimore); 2022 Sep; 101(39):e30681. PubMed ID: 36181111 [TBL] [Abstract][Full Text] [Related]
56. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC. Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338 [TBL] [Abstract][Full Text] [Related]
57. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network. Hu D; Zhang B; Yu M; Shi W; Zhang L Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035 [TBL] [Abstract][Full Text] [Related]
58. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma. Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748 [TBL] [Abstract][Full Text] [Related]
59. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p. Jiang G; Dong H; Dong Y; Yang X Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416 [TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma. Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]